Brief: Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam For Tsc-Related Epilepsy
04/08/2025 12:59
Aug 4 (Reuters) - Cassava Sciences Inc SAVA.O: CASSAVA SCIENCES REPORTS POSITIVE PRECLINICAL STUDY EVALUATING SIMUFILAM FOR TSC-RELATED EPILEPSY CASSAVA SCIENCES INC - CLINICAL STUDY FOR SIMUFILAM IN TSC EPILEPSY EXPECTED IN H1 2026 Source text: ID:nGNXbPpxDk Further company coverage: SAVA.O ((Reuters.Briefs@thomsonreuters.com;))